Subtypes of Clinical High Risk for Psychosis that Predict Antipsychotic Effectiveness in Long-Term Remission
- 12 October 2020
- journal article
- research article
- Published by Georg Thieme Verlag KG in Pharmacopsychiatry
- Vol. 54 (01) , 23-30
Abstract
Introduction In a previous report, we used canonical correlation analysis to classify individuals with clinical high risk (CHR) of psychosis into the 3 subtypes: subtype-1, characterized by extensive negative symptoms and cognitive deficits, appeared to have the highest risk for conversion to psychosis; subtype-2, characterized by thought and behavioral disorganization, with moderate cognitive impairment; subtype-3, characterized by the mildest symptoms and cognitive deficits. The present study attempted to identify these subtypes’ response to antipsychotic (AP) treatment. Methods A total of 289 individuals with CHR were identified and followed up for 2 years. Individuals with CHR were classified by subtype. Use of APs was examined at 2-month, 1-year, and 2-year follow-up interviews that inquired after the subjects’ medication history since the first visit. The main outcome was remission, determined according to global assessment of function (GAF) score (i. e., functional outcome) and SIPS positive symptom score (symptomatic outcome) at the follow-up points. Results Among the 289 individuals with CHR included in the current analysis, 223 (77.2%) were treated using APs for at least 2 weeks during the follow-up period. Individuals with CHR tended to show significant improvement in both symptoms and function after 2 years, but subtypes exhibited significantly different trajectories. Subtype status can predict AP treatment outcome in terms of remission. The likelihood of remission differed significantly among the subtype groups. The remission rates for individuals with subtypes 1–3 treated using AP were 13.5%, 36.1%, and 67.0%, respectively. Discussion These subtypes may be of clinical value in AP treatment decision-making in the CHR population. + The author shares first authorship. Received: 06 July 2020 Received: 20 August 2020 Accepted: 21 August 2020 Article published online: 12 October 2020 © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyKeywords
Funding Information
- Ministry of Science and Technology of China, National Key R&D Program of China (2016YFC1306800)
- National Natural Science Foundation of China (81671329)
- National Natural Science Foundation of China (81671332)
- National Natural Science Foundation of China (81901832)
- Shanghai Key Laboratory of Psychotic Disorders (13dz2260500)
- Science and Technology Commission of Shanghai Municipality (No.2018SHZDZX01)
- Science and Technology Commission of Shanghai Municipality (19ZR1477800)
- Science and Technology Commission of Shanghai Municipality (19ZR1445200)
- Science and Technology Commission of Shanghai Municipality (19441907800)
- Science and Technology Commission of Shanghai Municipality (17411953100)
- Science and Technology Commission of Shanghai Municipality (19410710800)
- Science and Technology Commission of Shanghai Municipality (19411969100)
- Science and Technology Commission of Shanghai Municipality (20ZR1448600)
- Science and Technology Commission of Shanghai Municipality (20ZR1448600)
- Shanghai Clinical Research Center for Mental Health (19MC1911100)
- Clinical Research Center at Shanghai Mental Health Center (CRC2018ZD01)
- Clinical Research Center at Shanghai Mental Health Center (CRC2018ZD04)
- Clinical Research Center at Shanghai Mental Health Center (CRC2018YB01)
This publication has 38 references indexed in Scilit:
- Progressive decline of cognition during the conversion from prodrome to psychosis with a characteristic pattern of the theory of mind compensated by neurocognitionSchizophrenia Research, 2018
- Psychosis-risk criteria in the general population: frequent misinterpretations and current evidenceWorld Psychiatry, 2018
- Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult communityPsychological Medicine, 2017
- A study on negative and depressive symptom prevalence in individuals at ultra‐high risk for psychosisEarly Intervention in Psychiatry, 2016
- Further examination of the reducing transition rate in ultra high risk for psychosis samples: The possible role of earlier interventionSchizophrenia Research, 2016
- Declining transition rates to psychotic disorder in “ultra-high risk” clients: Investigation of a dilution effectSchizophrenia Research, 2016
- Psychotic symptoms, functioning and coping in adolescents with mental illnessBMC Psychiatry, 2014
- Declining Transition Rate in Ultra High Risk (Prodromal) Services: Dilution or Reduction of Risk?Schizophrenia Bulletin, 2007
- Prospective Diagnosis of the Initial Prodrome for Schizophrenia Based on the Structured Interview for Prodromal Syndromes: Preliminary Evidence of Interrater Reliability and Predictive ValidityAmerican Journal of Psychiatry, 2002
- Prediction of psychosisThe British Journal of Psychiatry, 1998